Molecular Omics

Molecular Omics is a peer-reviewed journal for research that applies genomics, transcriptomics, proteomics and metabolomics to chemical and biological problems, with an emphasis on mechanistic insight into biological processes.《分子组学》是一份同行评审期刊，刊登以基因组学，转录组学，蛋白质组学，代谢组学等手段解答化学与生物学问题的研究，重心放在对生物过程的机制性解释上。

Launched in 2018 by the Royal Society of Chemistry as the successor to Molecular BioSystems, it moved to Oxford University Press in January 2026 without changing its title or electronic ISSN.该刊的前身是英国皇家化学会（Royal Society of Chemistry）2005 年创办的《分子生物系统》（Molecular BioSystems），2018 年更名并沿用原卷号，2026 年 1 月起转由牛津大学出版社（Oxford University Press）出版，刊名与电子刊号未变。

Scope

• The stated remit is wide, since any scientific work built on the application of an omics technology falls inside it, and combinations of several omics platforms are actively encouraged.收录范围写得宽，凡以某一组学技术的应用为基础的科学工作都在其中，把多个组学平台的数据合起来做的研究更受鼓励。
• Mechanistic work forms one pillar, covering studies that use omics data to explain how a drug acts, or why a genotype produces a phenotype such as drought tolerance in crops.机制解析是一大支柱，用组学数据说明药物如何起作用，或说明某一基因型为何带来耐旱一类表型的论文属于核心选题。
• Clinical translation is the second strand, and omics studies aimed at diagnosis receive a hearing when the findings carry independent validation, including candidate biomarkers and new drug targets for development.临床转化是第二条主线，面向诊断的组学研究要有独立验证才站得住，候选生物标志物与新的药物靶点都在此列。
• A third strand looks inside the cell, taking in subcellular localisation of proteins, post-translational modifications, and imaging techniques that resolve molecular composition at a scale finer than bulk tissue analysis allows.第三类稿件把镜头对准细胞内部，蛋白质的亚细胞定位，翻译后修饰，以及能在更细尺度上分辨分子组成的成像技术都属此范围。
• Methodological papers are equally welcome, whether they present spectroscopic or chromatographic techniques, chip-based and array formats, or new ways of classifying and analysing large datasets.方法学论文同样受欢迎，光谱与色谱新技术，芯片和阵列形式，以及新的数据分类与分析方法都算，前提是论文把改进演示到位。
• Genomics and transcriptomics supply much of the sequence-level evidence, from variant discovery to expression profiling across tissues, treatments and developmental stages, and both are treated as core inputs.基因组学与转录组学提供序列层面的主要证据，从变异发现到跨组织，跨处理，跨发育阶段的表达谱，这两类数据被当作核心输入。
• Proteomics and metabolomics contribute the mass-spectrometry side of the field, where quantification of peptides and small molecules carries the argument about what a cell actually does at a given moment.蛋白质组学与代谢组学撑起质谱一侧，肽段与小分子的定量决定了论证能否说清一个细胞在特定时刻究竟在做什么。
• Specialised branches such as glycomics and lipidomics are named explicitly in the aims, which keeps carbohydrate and lipid profiling inside the main scope rather than at its edge.糖组学与脂质组学在收录说明里被单独点名，糖链和脂质的谱学分析因此处在正题之内，而不被推到边缘。
• Innovative bioinformatics is treated as part of the science rather than a service add-on, and papers that build analysis pipelines or statistical models for omics data are reviewed on their own merits.有创见的生物信息学被视为科学本身，不当作附加服务，为组学数据搭建分析流程或统计模型的论文按自身价值评审。
• Multi-omics integration sits at the centre of the project, since the journal asks for work that joins several platforms to answer a question no single dataset could settle on its own.多组学整合处在办刊思路的中心，刊物要的是把几个平台的数据接起来，回答单一数据集无法定论的问题。
• The editors set a high bar for significance, and results that could be predicted routinely from earlier work, or that matter only to specialists in a narrow corner of the field, are turned away.编辑对重要性设了门槛，能从既有工作里常规预测出的结果，或只对某个狭窄分支的专家有意义的稿件，通常会被退回。
• Because the readership spans chemistry, biology and computation, a paper is expected to explain its biological question and its computational choices in language the neighbouring discipline can follow.读者横跨化学，生物学与计算科学，论文因此要把生物学问题和计算上的取舍讲清楚，让隔壁学科的同行也读得懂。
• Reviews and shorter communications sit alongside full research papers, giving authors room either to summarise a fast-moving area or to report a result that needs rapid circulation among specialists.综述与较短的通讯类稿件和完整研究论文并列发表，作者既可以梳理一个变化很快的方向，也可以尽快公布一个结果。

History

• The title has a lineage, since the Royal Society of Chemistry launched Molecular BioSystems in 2005 as a forum for chemical biology and systems-level thinking about biological molecules.这份刊物有前身，英国皇家化学会（Royal Society of Chemistry）2005 年创办《分子生物系统》（Molecular BioSystems），为化学生物学以及从系统层面理解生物分子的研究提供阵地。
• Thirteen volumes appeared under that name, and the 2018 relaunch as Molecular Omics began at volume 14, so the numbering runs unbroken across the change of title.旧名之下出了 13 卷，2018 年更名后从第 14 卷接着编，卷号跨越这次换名没有中断。
• Volume 14 carried six issues through 2018, a bimonthly rhythm the journal kept for its first four volumes, up to volume 17 in 2021, when issues still appeared two months apart.第 14 卷在 2018 年出了 6 期，双月的节奏保持了最初四卷，直到 2021 年的第 17 卷仍是每两个月一期。
• Indexing followed quickly, with MEDLINE and PubMed covering the journal from volume 14, issue 1, which gave the new title a place in biomedical searching from its first year.收录跟进得很快，MEDLINE 与 PubMed 从第 14 卷第 1 期起全文覆盖，新刊名一开始就进入了生物医学检索体系。
• The relaunch tracked a shift in the field itself, because sequencing and mass spectrometry had made large-scale measurement routine in chemistry departments, and a journal devoted to that work made sense.这次更名对应着学科本身的变化，测序与质谱让大规模测量成为化学系里的常规工作，专做这类研究的刊物随之有了立足点。
• From 2022 the schedule changed, with volume 18 running to ten issues, and volumes 19 and 20 in 2023 and 2024 following the same ten-issue pattern year after year.2022 年起刊期变了，第 18 卷扩到 10 期，2023 年的第 19 卷与 2024 年的第 20 卷延续了这一节奏。
• In 2025 that expansion was reversed, and volume 21 returned to six issues, the count volume 22 has carried into 2026 under the new publisher so far.2025 年这次扩版被收回，第 21 卷回到 6 期，2026 年第 22 卷在新出版方手里仍按这个数目出刊。
• Ownership of the imprint moved in 2026, and the National Library of Medicine now records the publisher as Oxford University Press, with Oxford as the place of publication from that year.出版方在 2026 年换了手，美国国家医学图书馆的刊目记录已把出版者写成牛津大学出版社（Oxford University Press），出版地也改为牛津。
• The Royal Society of Chemistry announced the transfer for January 2026 and kept the journal's own page live, pointing readers from there to its new home at the university press.英国皇家化学会在原刊页上公布了 2026 年 1 月转让出版一事，页面保留下来，同时把读者引向大学出版社的新址。
• No renaming came with the move, and the electronic ISSN stayed as it was, so citations, links and repository records of papers already published under the old imprint survived intact.这次转移没有带来改刊名，电子刊号原封不动，已发表文献的引文，链接与仓储记录因此不受影响。
• The impact factor has slid since the mid-2020s, from 4.212 for 2022 and 3.0 for 2023 to 2.4 in both 2024 and 2025, with a five-year figure of 3.0.影响因子近三年走低，2022 年为 4.212，2023 年为 3.0，2024 年与 2025 年都是 2.4，五年影响因子为 3.0。
• By the 2025 Journal Citation Reports the journal had accumulated 1,131 citations and published 37 articles that year, a small output that keeps the title selective rather than volume-driven.按 2025 年的期刊引证报告，该刊累计被引 1131 次，当年发文 37 篇，产出规模不大，选稿因此偏严而不靠数量取胜。
• Access has stayed hybrid, since most papers sit behind a subscription while authors who pay an article processing charge can make theirs open, and about 27 percent of 2025 content did so.订阅与开放并存，多数论文仍需订阅阅读，作者支付文章处理费后可开放获取，2025 年的内容里约 27% 走了这条路。
• The same reports place the journal in the third quartile of biochemistry and molecular biology, ranked 244th of 328 titles in that category on the Journal Impact Factor.2025 年的期刊引证报告把该刊放在生化与分子生物学类别的第三四分位，影响因子排名为该类 328 种期刊中的第 244 位。
• Beyond the biomedical indexes, Scopus and the Web of Science core collection both list the title, which widens the pool of departments willing to count its papers as output.除生物医学检索库之外，Scopus 与 Web of Science 核心合集也收录该刊，愿意把它的论文算作成果的院系范围因此更宽。

Editors

• Robert Moritz of the Institute for Systems Biology in Seattle holds the editor-in-chief post, and his own work centres on mass-spectrometry proteomics and targeted protein measurement in complex samples.主编是 Robert Moritz，供职于西雅图的 Institute for Systems Biology，本人的研究集中在质谱蛋白质组学与复杂样品中的靶向蛋白定量。
• He builds assays that let a laboratory measure a specific protein across many samples, an interest that matches the journal's taste for methods whose usefulness has been demonstrated in practice.他研究的是让实验室能在大量样品中测定特定蛋白的分析方法，这与刊物偏爱经过实际检验的方法学论文正好合拍。
• Day-to-day handling is shared with associate editors, each covering a slice of the field, and with an international editorial board whose members referee papers and advise on policy.日常稿件分给几位副编辑，各管领域里的一块，另有一个国际化的编委会负责审稿与政策建议。
• Every submission is read by an editor before review, and papers outside the remit, or too preliminary to survive refereeing, are returned quickly to save authors time.每篇稿件先由编辑过目再决定是否送审，超出范围或尚不成熟的论文会被尽快退回，替作者省下等待时间。
• At least two independent referees normally assess each paper, their identities are withheld from authors, and the reports reach the author in full alongside the editor's decision letter.每篇论文通常由两位以上独立审稿人评估，审稿人身份对作者保密，审稿意见随编辑决定一并转给作者。
• Revisions stay with the same editor, who judges whether the referees' points have been met, and an author who disagrees with the outcome can appeal the decision in writing.修回稿仍由同一位编辑处理，由他判断审稿意见是否落实，作者若有异议可以书面申诉。
• Review articles are often discussed with the editorial office before writing begins, which keeps commissioned coverage from overlapping with material already in press or under review elsewhere.综述动笔前多与编辑部沟通选题，这样可以避开与已排期或正在他处评审的内容撞题。
• Ethics and data policies follow the publisher's framework, so authorship contributions must be stated, competing interests declared, and omics datasets deposited in public repositories wherever a suitable one exists.伦理与数据政策沿用出版方的框架，作者贡献要写明，利益冲突要申报，组学数据在有合适公共库的情况下须提交入库。
• Corrections and retractions carry a DOI of their own and are linked to the original paper, so the published record stays readable years after a claim has been revised.更正与撤稿声明单独给出 DOI 并与原文互链，多年前的结论即使被修正，读者顺着记录仍能看清来龙去脉。
• Board members come from universities and research institutes across several continents, a spread that helps the editors find referees outside an author's own circle and language community.编委来自几大洲的大学与研究机构，这种分布让编辑更容易找到作者圈子之外的审稿人，处理跨领域稿件时尤其有用。
• Correspondence with the journal runs through the publisher's submission system, and the editorial office answers scope queries before a manuscript is formally submitted, which saves a full round of review.与刊物的往来都走出版方的投稿系统，正式投稿之前可以先向编辑部询问选题是否在范围内，这样能省下一整轮评审。
• Statistical reporting gets attention at review, and papers that rely on machine learning are expected to describe training data, validation and the risk of overfitting in terms a biologist can judge.统计层面的交代是评审关注点，依赖机器学习的论文要说明训练数据，验证方式与过拟合风险，并且写得让生物学家也能判断。
• One editor signs each decision, and where referees disagree that editor weighs the arguments instead of counting votes, which keeps borderline methodological papers from failing by default.每个决定由一位编辑签发，审稿人意见相左时由编辑权衡理由，不靠票数定去留，处在边缘的方法学论文因此不至于被默认退掉。